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Abstract This study investigates the expression of
hypoxia-inducible factor-l alpha (HIF-1a) and carbonic
anhydrase IX (CAIX) in nasopharyngeal carcinoma (NPC)
tissues and their correlation with clinicopathological fea-
tures and prognosis in NPC patients. The expression of
HIF-1a and CAIX proteins was detected by immunohis-
tochemical staining in 129 samples of NPC and 20 samples
of chronic nasopharyngitis. The correlations between the
expression of these two proteins and clinicopathological
features and prognosis were evaluated in NPC patients. Our
results showed that the positive expression rates of HIF-1a
and CAIX proteins in NPC were significantly higher than
those in chronic nasopharyngitis (both P \ 0.01). In
addition, high HIF-1a protein expression was correlated
with lymph node metastasis and advanced clinical stage for
NPC patients (both P \ 0.01), whereas there were no
findings of correlations between CAIX protein expression
and gender, age, T stage, node involvement and clinical
stage (all P [ 0.05). The Spearman analysis indicated that
HIF-1a was positively correlated with CAIX expression
(r = 0.249, P = 0.004). HIF-1a and CAIX co-expression
was associated with the poor overall survival (OS), pro-
gression-free survival (PFS), loco-regional relapse-free
survival (LRRFS) and distant metastasis-free survival
(DMFS) in NPC patients (P = 0.017, P = 0.022,
P = 0.033, and P = 0.017, respectively). Multivariate
analysis showed that the positive expression of CAIX
protein was an independent prognostic factor for PFS,
LRRFS and DMFS. In conclusion, overexpression of HIF-
1a and CAIX might be involved in the carcinogenesis and
development of NPC and they were associated with
patients’ poor prognosis.
Keywords Nasopharyngeal carcinoma  Hypoxia-
inducible factor-1 alpha  Carbonic anhydrase IX 
Prognosis
Introduction
Nasopharyngeal carcinoma (NPC) is one of the most
common malignancies in China and Southeast Asia areas
[1]. With the development of radiotherapy technology and
the combined application of radiochemistry, the therapeu-
tic efficacy is gradually improved, but it still fails to
achieve the desired effect because of local recurrence and
distant metastasis [2].
Hypoxia is one of the most common characteristics in
many solid cancers. Tumor hypoxia is known to be mainly
responsible for tumor resistance to radiotherapy and che-
motherapy as well as to promote tumor phenotype influ-
encing invasiveness, metastasis and poor prognosis [3].
There is now evidence to indicate that cells triggering an
adaptive response to hypoxia conditions are mediated by
hypoxia-inducible factor-1 (HIF-1)-dependent pathway in
cancer. HIF-1 is a heterodimeric basic helix-loop-helix
transcription factor consisting of HIF-1a and HIF-1b sub-
units. The biological function of HIF-1 is mainly deter-
mined by the expression and activity of HIF-1a [4]. HIF-1a
plays a major role in several aspects of tumor biology, such
as glucose uptake, metabolism, growth rate, angiogenesis,
invasiveness, metastasis and apoptosis [5]. Overexpression
of HIF-1a is common in many malignancies and has been
found to be correlated with a poor prognosis of different
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types of tumor. Kitagawa et al. [6] reported that the NPC
patients with overexpression of HIF-1a had significant
worse prognosis.
Under hypoxic conditions, HIF-1 is activated and
induces the up-regulation and overexpression of a variety
of genes. Among these genes, carbonic anhydrase IX
(CAIX) is significantly over expressed in a variety of
malignancies [7]. CAIX is an isomeric member of the CA
family, whose main function is to catalyze the reversible
reaction of CO2 hydration, involved in the maintenance of
normal intracellular pH value and regulation of extracel-
lular acidic microenvironment formation enhancing tumor
cell growth, invasiveness and migration [8]. It indicates
that CAIX plays an important role in the development and
progression of malignant tumor. Several findings have
showed that CAIX expression is related to poor prognosis
[9, 10]. Although CAIX alone had not showed any prog-
nostic effect for NPC patient outcome, previous study have
confirmed that CAIX predicts poor prognosis for other
types of head and neck cancer, such as laryngeal carcinoma
[11].
Therefore, it is essential to identify the biological
markers associated with the diagnostic and prognostic
features of NPC. In this study, we identified the expression
of HIF-1a and CAIX in NPC patients and assessed their
correlations with clinicopathological features and progno-
sis of patients.
Materials and methods
Patients and tumor biopsies
We obtained 129 tumor specimens from NPC patients who
had been diagnosed at the second clinical medicine college
of Jinan University, China, from December 2006 to August
2011. The tumor biopsies were taken prior to patients
received chemotherapy or radiotherapy at the time. Twenty
samples of chronic nasopharyngitis were used as controls.
Of 129 patients, there were 99 men and 30 women, with a
median age of 43 years (range 20–77). The patients’
characteristics are shown in Table 1. Clinical status was
determined according to the 2010 American Joint Com-
mittee on Cancer (AJCC, 7th edition). All patients were
received either standard curative radiotherapy with or
without chemotherapy. The last follow-up date was at the
end of December 2013, and the median time of follow-up
was 52.4 months (range 8.6–84.1). The current project was
approved by the local ethics committee, and informed
consent was obtained from all patients.
Immunohistochemical staining and evaluation
Immunohistochemical staining of HIF-1a and CAIX
expressions was performed on 4-lm sections from NPC
paraffin-embedded tissues. After de-paraffinisation and
hydration, antigen retrieval was performed by pressure
cooking for 20 min in citric acid buffer. The sections
were treated with 3 % hydrogen peroxide for 10 min to
block endogenous peroxidase activity. Each section was
incubated with protein blocker for 15 min at room tem-
perature followed by mouse anti-human HIF-1a anti-
body(1:100, Novus Biologicals, Colorado, USA) and
rabbit anti-human CAIX antibody (1:400, Novus Biolog-
icals, Colorado, USA)incubation at 4 C overnight. After
washing with PBS, the sections were incubated with
secondary antibody for 20 min at room temperature. The
reaction products were developed using diamidobenzidine
tetrahydrochloride (DAB) solution (Cell Signaling Tech-
nology, CA, USA) for 10 min. The sections were coun-
terstained with hematoxylin.
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Using PBS instead of primary antibody as negative
control was conducted for each staining. Known positive
results from the prepared experiments were used as posi-
tive control. For each slide, five arbitrarily separated
microscopic fields (4009) with every field containing[100
tumor cells were evaluated by two pathologists blinded to
the clinical data. The brown granules in nuclear membrane
were considered as positive staining for HIF-1a while in
cell membranes or cytoplasm for CAIX. Staining intensity
was scored as follows: 0, no staining; 1, weak staining; 2,
moderate staining; and 3, strong staining. Scores for the
percentage of immunopositive cells were rated as follows:
0, \10 % positive cells; 1, 10–25 %; 2, 25–50 %; and 3,
[50 % positive cells. Taking the scores of intensity of
staining and percentage of immunopositive cells together,
the cases were classified into negative group with scores
B2 and positive group with scores [2.
Statistical analysis
The clinical characteristics of patients in relation to HIF-1a
and CAIX expressions were analyzed using the Chi-square
test. The Spearman correlation test was used to analyze the
correlation between HIF-1a and CAIX expressions in NPC.
Association of expression of HIF-1a and CAIX with
overall survival, progression-free survival, loco-regional
relapse-free and distant metastasis-free survival rates were
determined in Kaplan–Meier analyses and log-rank test.
The Cox regression analysis was used for multivariant
analysis. P \ 0.05 was considered statistically significant.
Statistical analysis was carried out using SPSS version 16.0
(SPSS, Chicago, IL, USA). Overall survival (OS) was
defined as the time from the start of radiotherapy to the
date of death or last follow-up. Progression-free survival
(PFS) was defined as the time from the start of radiotherapy
to the date of progression (loco-regional relapse or distant
metastasis) or last follow-up. Loco-regional relapse-free
survival (LRRFS) was defined as the time from the start of
radiotherapy to the date of loco-regional relapse or last
follow-up. Distant metastasis-free survival (DMFS) was
defined as the time from the start of radiotherapy to the
date of distant metastases or last follow-up.
Results
Expression of HIF-1a and CAIX in NPC and chronic
nasopharyngitis
The expression of HIF-1a and CAIX was examined by
immunohistochemical staining in NPC biopsy specimens
(Fig. 1). Of 129 NPC biopsy sections, positive expression
of HIF-1a and CAIX was observed in 53.5 % (69/129) and
56.6 % (73/129) of NPC samples, respectively. While in 20
samples of chronic nasopharyngitis, no positive expression
of HIF-1a was detected and there was 15 % (3/20) of
sections with CAIX positive expression. The positive rates
of HIF-1a and CAIX expressions in NPC were signifi-
cantly higher than chronic nasopharyngitis (v2 = 19.924,
P \ 0.01; v2 = 11.985, P \ 0.01). The Spearman analysis
revealed that HIF-1a expression was positively correlated
with CAIX expression (r = 0.249, P = 0.004).
Relationship between expression of HIF-1a and CAIX
proteins and clinicopathological features
HIF-1a expression was significantly correlated with lymph
node stage and clinical stage, but there was no significant
association between HIF-1a expression and age, gender
and T stage. There was no relationship between CAIX
expressions with any of the following clinical parameters:
age, gender, primary tumor stage, lymph node stage and
clinical stage (Table 2).
Prognosis analysis
To the date of last follow-up, there were 18 patients with
loco-regional relapse, 20 patients with distant metastasis
and 29 deaths. NPC patients’ 5-year OS, PFS, LRRFS and
DMFS with respect to HIF-1a and CAIX status are sum-
marized in Table 3. NPC patients with positive expression
of HIF-1a had poor OS and DMFS than those with nega-
tive HIF-1a expression. However, HIF-1a expression had
no influence on the PFS and LRRFS. For the survival of
CAIX, CAIX positive cases had worse OS, PFS, LRRFS
and DMFS than CAIX negative cases. Kaplan–Meier sur-
vival curves showed that patients with both HIF-1a and
CAIX positive expressions were associated with poorer
OS, PFS, LRRFS and DMFS than those with both HIF-1a
and CAIX negative expressions (Fig. 2). Moreover, a
univariate analysis by Kaplan–Meier method also showed
that age, Karnofsky Performance Scale (KPS), node
involvement and clinical stage were associated with a poor
prognosis (P \ 0.05). Finally, a multivariate Cox regres-
sion analysis revealed that significantly independent prog-
nostic factors for OS were age and clinical stage.
Significantly independent prognostic factors for PFS,
LRRFS and DMFS were age, KPS and the expression of
CAIX protein (Table 4).
Discussion
In our study, we found that positive staining of HIF-1a was
detected in 53.5 and 0 % of nasopharyngeal carcinoma
cases and chronic nasopharyngitis tissues, respectively.
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This is in agreement with previous reports of HIF-1a which
was over expressed in NPC [12–14]. Shou et al. [15]
reported that HIF-1a expression was significantly
associated with high T stage and lymph node metastasis.
Our study showed that positive expression of HIF-1a
protein was correlated with node involvement and clinical




9400). a Nuclear membrane
positive staining of HIF-1a in
NPC tissue. b Plasmalemma and
cytoplasmic positive staining of
CAIX in NPC tissue
Table 2 Correlation between
expression of HIF-1a and CAIX
and clinicopathological features
Significant results are given in
bold
Variables Total HIF-1a P value CAIX P value
Positive (%) Negative (%) Positive (%) Negative (%)
Gender
Male 99 53 (53.5) 46 (46.5) 0.984 57 (57.6) 42 (42.4) 0.681
Female 30 16 (53.3) 14 (46.7) 16 (53.3) 14 (46.7)
Age(years)
\50 88 42 (47.7) 46 (52.3) 0.055 48 (54.5) 40 (45.5) 0.493
C50 41 27 (65.9) 14 (34.1) 25 (61.0) 16 (39.0)
T classification
T1?2 79 39 (49.4) 40 (50.6) 0.238 43 (54.4) 36 (45.6) 0.534
T3?4 50 30 (60.0) 20 (40.0) 30 (60.0) 20 (40.0)
N classification
N0 9 1 (11.1) 8 (88.9) 0.008 3 (33.3) 6 (66.7) 0.144
N1–3 120 68 (56.7) 52 (43.3) 70 (58.3) 50 (41.7)
Clinical stage
I ? II 30 7 (23.3) 23 (76.7) 0.000 13 (43.3) 17 (56.7) 0.094
III ? IV 99 62 (62.6) 37 (37.4) 60 (60.6) 39 (39.4)
Table 3 Association of HIF-1a
and CAIX expressions with
5-year survival in NPC patients
Significant results are given in
bold
OS overall survival, PFS
progression-free survival,
LRRFS loco-regional relapse-
free survival, DMFS distant
metastasis-free survival
Group 5-year OS 5-year PFS 5-year LRRFS 5-year DMFS
Rate (%) P value Rate (%) P value Rate (%) P value Rate (%) P value
HIF-1a
Positive 71.5 0.023 73.0 0.074 72.4 0.072 72.4 0.030
Negative 79.6 81.5 81.8 79.3
CAIX
Positive 68.5 0.044 67.3 0.035 67.9 0.046 67.5 0.042
Negative 76.7 77.4 76.8 77.6
HIF-1a and CAIX
Both positive 63.4 0.017 64.7 0.022 65.3 0.033 62.7 0.017
Both negative 72.3 72.6 72.3 73.0
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stage for NPC patients, but not with age, gender and T
stage of NPC patients. Gong et al. [16] conducted a sys-
tematic review from 28 studies to assess the association
between HIFs and head and neck cancer (HNC) and
showed that overexpression of HIFs was significantly
associated with the increase of mortality risk survival in
HNC and worse OS in nasopharyngeal carcinoma.
Moreover, other findings have showed that positive
expression of HIF-1a was associated with a higher distant
metastasis, a worse overall and disease-free survival in
NPC patients [14]. Similar to their results, we found that
patients with high expression of HIF-1a were significantly
associated with worse OS and DMFS, but the level of HIF-
1a expression had no effect on PFS and LRRFS. From
Fig. 2 The Kaplan–Meier
curves for NPC patients with
both positive and negative
expressions of HIF-1a and
CAIX: a overall survival,
b progression-free survival,
c loco-regional relapse-free
survival, d distant metastasis-
free survival
Table 4 The result of
multivariate analysis of NPC
patients after radiotherapy
OS overall survival, PFS
progression-free survival,
LRRFS loco-regional relapse-
free survival, DMFS distant
metastasis-free survival, KPS
Karnofsky Performance Scale,
SE standard error, RR risk ratio,
CI confidence interval
Variables b value SE value Chi-square value P value RR (95 % CI)
OS
Age 0.065 0.017 14.727 0.000 1.067 (1.032–1.103)
Clinical stage 0.701 0.305 5.274 0.022 2.016 (1.108–3.666)
PFS
Age 0.074 0.017 19.064 0.000 1.077 (1.042–1.114)
KPS -0.786 0.276 8.093 0.004 0.456 (0.265–0.783)
CAIX 1.093 0.434 6.333 0.012 2.983 (1.273–6.987)
LRRFS
Age 0.078 0.018 19.666 0.000 1.081 (1.044–1.118)
KPS -0.728 0.265 7.574 0.006 0.483 (0.287–0.811)
CAIX 1.047 0.433 5.852 0.016 2.849 (1.220–6.653)
DMFS
Age 0.078 0.017 20.170 0.000 1.081 (1.045–1.118)
KPS -0.755 0.276 7.491 0.006 0.470 (0.274–0.807)
CAIX 1.016 0.432 5.542 0.019 2.762 (1.185–6.434)
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these results, we speculated that HIF-1a may enhance
cancer mortality by promoting distant metastasis. Moon
et al. [17] reported that metastasis-associated protein 1
enhanced angiogenesis by stabilization of the HIF-1a
transcription complex, which promoted tumor progression
and metastasis. Yang et al. [18] showed that overexpression
of HIF-1a not only promoted epithelial-mesenchymal
transition and metastastic phenotypes, but also up-regu-
lated the expression of the transcription factor TWIST, an
essential mediator of cancer metastasis, resulting in treat-
ment failure and mortality in malignancy. Jing et al. [19]
found that hypoxia-induced invasion and metastasis of
esophageal carcinoma was attributed to the distinctive
capacity of HIF-1a in inhibiting E-cadherin and promoting
matrix metalloproteinase-2 expression. The vascular
endothelial growth factor, cyclooxygenase-2 and isocitrate
dehydrogenase-2 were also found to be involved in the
regulation of HIF-1a signaling pathway for cancer angio-
genesis, invasiveness and metastasis [20–22].
We have found that CAIX was expressed in 56.6 % of
NPC biopsy specimens, and no association was identified
between the expression of CAIX and age, gender, tumor
stage, nodal stage and clinical stage. Our observations were
similar to those findings by other investigators in NPC [12].
These results suggest that CAIX probably involves in the
occurrence and development of NPC during which it keeps
an overexpression status. Peridis et al. [23] conducted
random-effect meta-analytical techniques to evaluate the
prognosis of head and neck cancer with CAIX expression
from sixteen studies and found that the presence of CAIX
in head and neck malignant tumors was associated with
reduced overall survival and disease-free survival. Hui
et al. [12] reported that there was no significant association
of the expression of CAIX with local recurrences and
distant metastases in NPC. However, our studies revealed
that positive expression of CAIX was significantly asso-
ciated with worse OS, PFS, LRRFS and DMFS in patients
with NPC receiving irradiation with or without chemo-
therapy. Multivariate analysis using the Cox’s regression
analysis showed that CAIX protein was an independent
prognostic indicator for patients’ PFS, LRRFS and DMFS.
It was found out that expression of the enzyme CAIX on
the tumor cell surface was involved in pH regulation by
hydrating cell-generated CO2 into HCO3
- and H? facili-
tating the extracellular trapping of acid, which contributed
to the acidification of the microenvironment favoring
tumor growth, invasion and development [24]. In addition,
CAIX had a capacity to reduce E-cadherin-mediated cell
adhesion via interaction with beta-catenin, while loss or
destabilization of E-cadherin, a key adhesion molecule,
was correlated with tumor invasion [25]. Moreover, several
important molecular regulators involved in cancer angio-
genesis, apoptosis inhibition and cell–cell adhesion
disruption, including epidermal growth factor receptor,
c-erbB-2 and MUC1, had been found to be associated with
the expression of CAIX, which might explain the rela-
tionship between CAIX and inferior prognoses [26].
Furthermore, we identified that the expression of HIF-1a
was significantly correlated with the expression of CAIX.
Similarly, Hui et al. [12] found that tumor expression of
HIF-1a was strongly relevant to that of CAIX in 90 patients
with NPC. The co-expression of HIF-1a with CAIX in cell
lines and their regulatory mechanisms have been well
documented. With regard to in vitro hypoxia experiment,
Wykoff et al. [27] found that hypoxia-inducible activity of
the CAIX promoter was mediated by HIF-1 pathway and
further study demonstrated that CAIX promoter was tightly
regulated by a HIF-1-dependent hypoxia response element
(HRE) lying adjacent to the initiation site. Since HIF-1a up-
regulates the expression of downstream genes CAIX, we
considered HIF-1a and CAIX as endogenous hypoxia-
related markers and found that both HIF-1a and CAIX
positive expression were associated with poor prognosis of
NPC. It is consistent with previous reports of overexpres-
sion of HIF-1a and CAIX correlating with a poor prognosis
in several types of cancer, including NPC, laryngeal carci-
noma, breast cancer and non-small cell lung cancer [28–30].
Our finding suggests that, besides primary radiotherapy,
some other supplementary treatment, such as hypoxia-
modifying and gene targeted therapy, should be considered
for NPC patients showing high HIF-1a or CAIX expression.
In summary, overexpression of HIF-1a and CAIX can
exploit synergies in carcinogenesis and development of
NPC. HIF-1a high expression was correlated with node
involvement, clinical stage and poor prognosis of NPC.
CAIX high expression was relevant to poor prognosis and
could serve as an independent prognostic factor in NPC.
Radiotherapy combined with HIF-1a related CAIX signal-
ing pathway targeted therapeutic approaches would be a
possible solution to improve therapeutic efficiency for NPC.
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